RE: COPD ASTHMA AND MORE17 May 2020 08:43
Firstly thanks to everybody who has located and put researched info on this forum, it has been really helpful, at least to me, in making decisions about whether or not to invest here.
Putting aside the considerable human cost of this pandemic for a moment, and viewing this purely in investment terms, this illness does seem to have provided Synairgen a fortuitous springboard to expedite the progress of SNG001 towards potential commercial development.
There seems to be growing evidence that interferon based treatments have a positive effect against Covid, and it would be life changing for us all if Synairgen has a role to play there. However, no one knows quite where we all are with this virus, and whether this will prove to be a short or long term issue for us all, but what we do know is COPD and its complications are likely to still be around for some time.
It is this potential market that I feel offers a balanced reason to invest in Synairgen at this time. If there are positive developments with the Covid trials, then, of course, that only significantly elevates this potential.
Just my view.
In the meantime, I have tried to find out, without success, if any of the home trials have actually started anywhere? There has been no further news on this since the announcement that it had been given approval to proceed.
Anyone got any further info on this?